The Role of Oncology Nurses in Discussing Clinical Trials

To describe oncology nurses' experiences discussing clinical trials with their patients, and to assess barriers to these discussions.
. A qualitative study designed to elicit narratives from oncology nurses. 
. Community- and academic-based oncology clinics throughout the United States.
. 33 on...

Full description

Saved in:
Bibliographic Details
Published inOncology nursing forum Vol. 44; no. 5; pp. 547 - 552
Main Authors Flocke, Susan A, Antognoli, Elizabeth, Daly, Barbara J, Jackson, Brigid, Fulton, Sarah E, Liu, Tasnuva M, Surdam, Jessica, Manne, Sharon, Meropol, Neal J
Format Journal Article
LanguageEnglish
Published United States Oncology Nursing Society 01.09.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:To describe oncology nurses' experiences discussing clinical trials with their patients, and to assess barriers to these discussions.
. A qualitative study designed to elicit narratives from oncology nurses. 
. Community- and academic-based oncology clinics throughout the United States.
. 33 oncology nurses involved in direct patient care in community-based and large hospital-based settings. The sample was drawn from members of the Oncology Nursing Society. 
. In-depth interviews were conducted and analyzed using a 
immersion/crystallization approach to identify themes and patterns. The analyses highlight specific issues, examples, and contexts that present challenges to clinical trial discussions with patients.
. Oncology nurses view their roles as patient educators and advocates to be inclusive of discussion of clinical trials. Barriers to such discussions include lack of knowledge and strategies for addressing patients' common misconceptions and uncertainty about the timing of discussions.
. These data indicate that enabling nurses to actively engage patients in discussions of clinical trials requires educational interventions to build self-efficacy and close knowledge gaps. 
. Oncology nurses can play a critical role in advancing cancer care by supporting patients in decision making about clinical trial participation. This will require training and education to build their knowledge, reduce barriers, and increase their self-efficacy to fulfill this responsibility in various clinical settings.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0190-535X
1538-0688
DOI:10.1188/17.ONF.547-552